COVID-19 vaccines (for Johnson & Johnson and AstraZeneca)
GPTKB entity
Statements (24)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
vaccine
|
| gptkbp:administeredBy |
intramuscular injection
|
| gptkbp:approvedBy |
gptkb:World_Health_Organization
gptkb:European_Medicines_Agency 2020 (AstraZeneca) 2021 (Johnson & Johnson) |
| gptkbp:developedBy |
gptkb:AstraZeneca
gptkb:Johnson_&_Johnson |
| gptkbp:dosingRegimen |
single dose (Johnson & Johnson)
two doses (AstraZeneca) |
| gptkbp:emergencyServices |
gptkb:United_States_Food_and_Drug_Administration
|
| https://www.w3.org/2000/01/rdf-schema#label |
COVID-19 vaccines (for Johnson & Johnson and AstraZeneca)
|
| gptkbp:includes |
gptkb:AstraZeneca_COVID-19_vaccine
gptkb:Johnson_&_Johnson_COVID-19_vaccine |
| gptkbp:marketedAs |
gptkb:Janssen_COVID-19_Vaccine
gptkb:Vaxzevria |
| gptkbp:sideEffect |
mild flu-like symptoms
rare blood clotting events |
| gptkbp:storage |
refrigerator temperature
|
| gptkbp:target |
gptkb:SARS-CoV-2_virus
|
| gptkbp:type |
viral vector vaccine
|
| gptkbp:usedFor |
prevention of COVID-19
|
| gptkbp:bfsParent |
gptkb:Emergent_BioSolutions
|
| gptkbp:bfsLayer |
5
|